Pulmonary Assessment in Thoracic Insufficiency Syndrome Patients
NCT ID: NCT04977830
Last Updated: 2025-05-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
15 participants
INTERVENTIONAL
2025-12-31
2026-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dual-function Semirigid Thoracoscopy Versus Rigid Thoracoscopy for the Diagnosis of Pleural Disease
NCT07114783
Pectus Excavatum Camouflage
NCT05451108
Techniques for Lung Deflation With Arndt® Blocker
NCT02030795
Evaluation of the Feasibility, Safety, and Efficacy of Single-use Endobronchial Silicon Spigots for the Treatment of Refractory Pneumothorax
NCT06515015
Investigation of the Effectiveness of Telerehabilitation Training in Pectus Excavatum Deformity
NCT06635083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thoracic Insufficiency Group
Thoracic insufficiency syndrome patients undergoing surgery
Xenon-129
Patients will undergo a hyperpolarized MRI with administered Xenon gas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Xenon-129
Patients will undergo a hyperpolarized MRI with administered Xenon gas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xemed LLC
INDUSTRY
Patrick Cahill, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Patrick Cahill, MD
Attending physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Cahill, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hopsital of Philadelphia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-017344
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.